KAREN KRIKORIAN: Open Payments
NPI 1801235486 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,134 in 44 payments from 18 companies in 2025. Trend: 2023 $143 · 2024 $823 · 2025 $1,134
Food & beverage: $1,134
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 11 | $257 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $184 |
| Kowa Pharmaceuticals America, Inc. | 3 | $90 |
| Abbott Laboratories | 3 | $89 |
| Janssen Pharmaceuticals, Inc | 2 | $66 |
| Dexcom, Inc. | 2 | $59 |
| Novo Nordisk Inc | 2 | $54 |
| Exact Sciences Corporation | 2 | $50 |
| Bausch Health US, LLC | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
Products named: CAPLYTA, ZORYVE, FREESTYLE LIBRE 3, SPRAVATO, Dexcom G6 Transmitter, Cologuard Collection Kit, APLENZIN, GVOKE HYPOPEN.
Industry payments across WA — which companies pay providers there.
